Endocrinologist explains dark side of weight loss drugs: Potential risks and benefits of Ozempic, Mounjaro, Wegovy

In an interview with HT Lifestyle, endocrinologist, Dr Saptarshi Bhattacharya, senior consultant, Indraprastha Apollo Hospitals, Delhi and secretary, Endocrine Society of Delhi, said that for some people, these anti-obesity injections, hailed as groundbreaking solutions, seem like a beacon of hope.

“Yet even as their popularity surges, a shadow of controversy looms. In the US, the manufacturers are facing legal trouble, with lawsuits claiming that they downplayed the risks of serious side effects associated with these products. These challenges make us pause and question the safety of these seemingly miraculous injections,” he said.

According to Dr Bhattacharya, while the manufacturing companies maintain that they did nothing wrong, scrutiny is increasing, urging everyone to reexamine the safety of these treatments: “Against this backdrop, it becomes important to turn to medical evidence rather than headlines.”